Health Idea Now
Friday, 21 June 2019
FDA declines to approve Daiichi Sankyo's blood cancer treatment
Japan's Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its drug quizartinib as a treatment for adults with a type of blood cancer.
from Reuters: Health News https://reut.rs/2XotflT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment